Type 1 Diabetes Pathway to Prevention Study (Natural History) Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Type 1 Diabetes
  • Age: Between 1 Year(s) - 45 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    Screening Phase:
    1. Subjects willing to give informed consent for screening.
    2. Subjects aged 2.5 to 45 years and a sibling, offspring, or parent of an individual with Type 1 Diabetes.
    3. Subjects aged 2.5 to 20 years and a niece, nephew, aunt, uncle, grandchild, cousin, or half sibling of an individual with Type 1 Diabetes
    4. Subjects who are not family members and are known to have 1 or more islet antibodies are eligible for screening if needed to determine eligibility for a clinical trial to delay or prevent disease progression
    Monitoring Phase:
    1. Subjects have 1 or 2 or more autoantibodies
    2. Subjects have a relative with Type 1 Diabetes.

You may not be eligible for this study if the following are true:

  • Screening Phase:
    1. Subjects have diabetes by 2011 ADA criteria.
    Monitoring Phase:
    1. Subjects have previous or current use of medications for the control of hyperglycemia/diabetes
    2. Subjects currently use immunosuppressive or immunomodulatory therapies, including pharmacologic doses of systemic steroids.
    3. Subjects have known severe active diseases, and/or diseases which are likely to limit life expectancy or lead to the use of chronic immunosuppressive or immunomodulatory therapies during the course of the study.
    4. Subjects have diabetes by 2011 ADA criteria, including a past history of diabetes
    5. Subjects be deemed unable or unlikely to comply with the protocol.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.